|
Volumn 250, Issue 2, 2001, Pages 154-159
|
Consequences of late referral of patients with end-stage renal disease
|
Author keywords
Chronic renal disease; End stage renal disease; Quality of care; Referral practice
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BICARBONATE;
CALCITRIOL;
CALCIUM;
PHOSPHATE BINDING AGENT;
SERUM ALBUMIN;
ADULT;
AGE;
AGED;
ALBUMIN BLOOD LEVEL;
ARTICLE;
CALCIUM BLOOD LEVEL;
CHRONIC KIDNEY FAILURE;
DIABETIC NEPHROPATHY;
FEMALE;
GLOMERULOPATHY;
HEMODIALYSIS;
HOSPITALIZATION;
HUMAN;
INTERSTITIAL NEPHRITIS;
KIDNEY ARTERIOVENOUS FISTULA;
KIDNEY POLYCYSTIC DISEASE;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
NEPHROLOGY;
PATIENT REFERRAL;
PERITONEAL DIALYSIS;
PRIORITY JOURNAL;
RENOVASCULAR HYPERTENSION;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
LENGTH OF STAY;
MALE;
MIDDLE AGED;
NORWAY;
PERITONEAL DIALYSIS;
QUALITY OF HEALTH CARE;
REFERRAL AND CONSULTATION;
REGISTRIES;
RENAL DIALYSIS;
RENAL REPLACEMENT THERAPY;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0034824616
PISSN: 09546820
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2796.2001.00869.x Document Type: Article |
Times cited : (92)
|
References (35)
|